Funded Startups in Warren
Among the 11 most recent funded entries shown, the largest disclosed round is Aquestive Therapeutics’ $55M (2026-05-12).
Among the 11 most recent funded entries shown, the largest disclosed round is Aquestive Therapeutics’ $55M (2026-05-12). That figure dwarfs the next-highest disclosed amounts in the table: $4M for Petra Power (2026-04-07) and $5M for Bellerophon Therapeutics (2023-03-06), with most other disclosed rounds landing in the $200K–$3M band or below (e.g., $150K on 2024-04-11, $50K on 2025-04-15, and multiple $10K rounds in 2023-08-23).
The data also clusters heavily around 2026 for the top of the list, with three of the 11 rows dated 2026-05-12 (Aquestive Therapeutics $55M; Tevogen Bio $3M) and 2026-04 (AXIA Time on 2026-04-21 is undisclosed; Petra Power $4M on 2026-04-07). Geography is split across Warren, with entries spread across New Jersey, Ohio, and Michigan. Sector-wise, “Series Unknown” dominates the disclosed/stated classifications (9 of 11 rows), while “undisclosed” amounts appear in 2 rows (AXIA Time on 2026-04-21; IO Connect Services on 2023-11-01).
Most recent rounds
11 shownRelated listings
Frequently asked
What’s the largest disclosed round in the Warren listings, and how does it compare to the rest of the disclosed amounts?
The largest disclosed round is Aquestive Therapeutics’ $55M on 2026-05-12. It sits far above the rest of the disclosed amounts in the table, where the next-largest disclosed entries are $5M (Bellerophon Therapeutics, 2023-03-06) and $4M (Petra Power, 2026-04-07).
Do multiple rounds concentrate in a narrow date window near the top of the list?
Yes. Three of the 11 rows are dated 2026-05-12, including a $55M round (Aquestive Therapeutics) and a $3M round (Tevogen Bio), and an additional cluster appears in mid-to-late April 2026 with Petra Power on 2026-04-07 ($4M) and AXIA Time on 2026-04-21 (undisclosed).
Which Warren geography appears most often, and is it evenly distributed across states?
Warren is split across multiple states rather than concentrated in one: Warren, New Jersey has 4 rows (Aquestive Therapeutics 2026-05-12; Tevogen Bio 2026-05-12; IO Connect Services 2023-11-01; Bellerophon Therapeutics 2023-03-06), while Warren, Ohio has 3 rows (Petra Power 2026-04-07; REM Electronics 2025-04-15; BRITE Energy Innovators 2024-04-11) and Warren, Michigan has 4 rows (Lakeshore Legal Aid 2025-04-17; Sticker Blitz 2023-08-23; Tech Serve4 U 2023-08-23; plus one other Michigan entry listed).
How does the stage mix look across these 11 rows?
“Series Unknown” dominates the stated stage for 9 of 11 rows. The only explicitly labeled stages shown are “Seed” for AXIA Time (2026-04-21, amount undisclosed) and “Series Unknown” for the remaining 9, including the largest disclosed rounds (Aquestive Therapeutics and Tevogen Bio on 2026-05-12).
Are there outliers in disclosed amounts or missing disclosure patterns?
In disclosed dollars, Aquestive Therapeutics’ $55M (2026-05-12) is the clear high outlier versus entries like REM Electronics at $50K (2025-04-15) and two $10K rounds on 2023-08-23 (Sticker Blitz; Tech Serve4 U). On disclosure, 2 of 11 rows list “undisclosed” amounts (AXIA Time on 2026-04-21 and IO Connect Services on 2023-11-01), which also limits comparability for those dates.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.